Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +2.40% to 10597.01, DAX +4.74% to 24007.18, CAC40 +4.40% to 8256.80, STOXX 600 +3.70% to 612.47

Apr 08 ,2026

  • Synopsis:

    • European equity markets, with the exception of Norway, opened higher, in a broad-based advance. Pan-European indices modestly extended opening gains, with the subsequent trajectory of the advance quickly moderating, shares slightly paring advances in later trade, ending around levels seen early in the session

    • Norway (3.2%) and Portugal +0.9% led underperformers, with Greece +6.6% and Ireland +6.2% leading outperformers.

    • Markets responded to the announcement by United States and Iran of a suspension of all attacks for two weeks (welcomed by the EU, others), and Tehran has agreed to allow the safe transit of vessels through the Strait of Hormuz. Iran says talks with US will begin in Pakistan's Islamabad on Friday and negotiations will be based on its 10-point proposal, which calls for control over Strait of Hormuz and lifting of all sanctions.

    • UK PM Starmer headed to Gulf to meet regional leaders (government press release) arriving in Saudi Arabia as he pushes for a long-term resolution to the Iran conflict. He is due to hold bilateral meetings with unspecified 'Gulf partners' and 'regional leaders'.

    • Norges Bank's Bache and Børsum were due to speak at Bank's regional network (Region Nord), topics are prospects for the Norwegian economy and the Government Pension Fund Global, and Longva at Bank's regional network (Region Sør-Vest ) topic prospects for the Norwegian economy.

    • Economic data included German factory orders that showed modest rebound m/m after last month's sharp decline, whilst UK house prices fell unexpectedly m/m in Mar, data from the Halifax showed. Eurozone Feb PPI and retail sales were inline with expectations, whilst Germany and UK Mar construction PMIs, topped estimates, though continue downturn. In Mar, Switzerland's seasonally adjusted unemployment rate holds steady m/m, whilst French trade deficit widened more than expected in Feb.

    • In European Parliament, committee business saw transport MEPs adopt their position on revised EU rules setting out common requirements for vehicle registration documents, whilst agriculture MEPs are expected to greenlight the deal reached with EU governments on new measures to reinforce farmers' position in the food supply chain.

    • Norway's minister of energy Aasland received report from Nuclear Power Committee. The report addresses nuclear power as a possible energy source in Norway.

    • In Denmark, it appears the current round of government formation negotiations will fail to conclude successfully, with a new round of talks likely to follow, again led by Mette Frederiksen

    • EU's Roswall hosts a roundtable discussion with Government representatives and industry on the Water Framework Directive.

    • Also, IATA World Data Symposium (through Thu). A Conf. on Climate Action in the Eastern Mediterranean and Middle East (through Thu). Friedrich Ebert Foundation event at 18:30CET title 'Between Free Trade and Sustainability - The Mercosur Agreement Under Scrutiny'

    • Corporate news flow was limited. Amongst the handful of companies with earnings/updates were Redcare Pharmacy (RDC.GR) reported prelim. Q1 revenue and reaffirmed its guidance for 2026, Evotec (EVT.GR) confirmed its prelim. FY25 earnings and FY26 guidance, Shell (SHEL.LN) published Q1 update note ahead of results and Lerøy Seafood Group (LSG.NO) issued Q1 harvest numbers - peers Måsøval (MAS.NO) and Grieg Seafood (GSF.NO) released the same data after the local market close. Also, Motorpoint Group (MOTR.LN) issued FY trading update and Close Brothers Group (CBG.LN) said the estimated cost of Motor finance consumer redress scheme was at ~£320M, broadly similar to group's existing provision. Reportedly, Bayer (BAYN.GR) executive says FY26 guidance unchanged following US announcement on patented pharmaceutical tariffs.

    • In M&A, Telefonica (TEF.SM) has reached an agreement to sell Telefónica México for $450M. Elsewhere, La Lettre reported that Danone (BN.FP) is again showing interest in buying Mead Johnson if Reckitt Benckiser (RKT.LN) decides to sell it. Gamma Communications (GAMA.LN) confirms preliminary discussions with multiple interested parties regarding a potential offer for the company. Following yesterday's announcement that Tinicum Inc. and Blackstone agree to acquire Senior (SNR.LN), Advent International confirmed that it does not intend to make an offer for the UK company

    • Elsewhere, REC Silicon (RECSI.NO) reports final results of rights issue and GSK's (GSK.LN) Exdensur (depemokimab) approved in China for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Travel & Leisure +6.96%, Ind Goods & Svcs +6.64%, Construct & Mtls +6.24%, Banks +5.70%, Technology +5.65%, Retail +5.55%, Basic Resources +5.18%, Autos & Parts +5.17%, Persnl & HHold Goods +4.76%, Real Estate +3.94%

      • Underperformers:

        • Oil & Gas (2.25%), Utilities +0.40%, Chemicals +1.37%, Insurance +1.91%, Food & Beverage +2.01%, Telecom +2.09%, Health Care +2.13%, Financial Svcs +3.34%, Media +3.56%

    • Macro/Peripheral markets:

      • Finland:

        • At the end of 2025, the value of the State's corporate holdings rose to ~ €38B - press release

      • France

        • To fast-track law to protect struggling farmers - Bloomberg

      • Greece:

        • To carry out its first exploratory hydrocarbon drilling in the Ionian Sea in Q1 of 2027 says minister - ekathimerini

      • Hungary:

        • Europe holds its breath ahead of Hungary's election - Lowy Institute

        • Opposition leader challenging Hungary's Viktor Orbán - Politico

        • Why Hungary's election matters - ITV

        • Election could have implications for EU, US, Russia, and Ukraine - Atlantic Council

        • Two fresh polls point to a tight finish - Daily News Hungary

      • Sweden:

        • Government commissions the Swedish Maritime and Water Management Agency to investigate the environmental impact of shipping in the Baltic Sea - press release

      • UK:

        • Experts say opening new oil and gas fields would miss climate goals - Guardian

        • Unions prepare for public sector pay push as UK inflation bites - FT

    • Company news:

      • Notable Gainers

        • +16.3% GAMA.LN (Gamma Communications) -- confirms preliminary discussions with interested counterparties in response to press speculation

        • +13.1% ALPHA.GA (Alpha Bank) -- reschedules Investor Day, initially planned for Q2 of 2026 to H2 of the year; reaffirms 2026 guidance

        • +12.9% CBG.LN (Close Brothers Group) -- estimates cost of Motor finance consumer redress scheme at ~£320M, broadly similar to group's existing provision

        • +9.6% RDC.GR (Redcare Pharmacy) -- prelim Q1 revenue €848M vs FactSet €824.0M [2 est, €815-833M]; confirms guidance for 2026

        • +8.1% DFCH.LN (Distribution Finance Capital Holdings: -- Q1 trading: new loan origination £469M, +23% y/y

        • +7.6% FAN.LN (Volution Group) -- outperform from neutral at Davy

        • +7.2% SPIE.FP (SPIE) -- overweight from equal-weight at Morgan Stanley

        • +7.2% EMEIS.FP (Emeis) -- confirms prelim FY25 results and guidance as per 17-Feb Update

        • +7.1% RMS.FP (Hermes) -- buy from neutral at CIC Market Solutions

        • +7.0% TTR1.GR (technotrans) -- major rail order for battery cooling

        • +7.0% GEKTERNA.GA (GEK Terna) -- FY net income €139.0M vs FactSet €129.6M [8 est, €72-178M]; proposes a dividend of €0.40/sh, unch y/y; provides outlook - slides

        • +6.0% YNGA.LN (Young & Co.'s Brewery) -- confirms it has agreed to acquire Cubitt House London Pubs

        • +6.0% BMPS.IM (Banca Monte dei Paschi di Siena) -- to unilaterally terminate labor contract with Luigi Lovaglio as general manager

        • +5.9% RSW.LN (Renishaw) -- appoints John Shipsey as CFO with effect from 13-Apr-26; also appoints Sir David Grant as its permanent Chair with immediate effect

        • +5.7% RCO.FP (Remy Cointreau) -- to launch transformation Plan "RC Forward"

        • +5.3% EVT.GR (Evotec) -- confirms prelim FY25 earnings and FY26 guidance as per 10-Mar update

        • +5.1% JUP.LN (Jupiter Fund Management) -- 2026 buyback program will commence on 8-Apr and is expected to be completed by no later than 8-Oct-26

        • +4.1% APTD.LN (Aptitude Software Group)

          • Launches strategic review, including a formal sale process; suspends share buyback; extends Chairman's tenure

          • FY EPS 13.0p ex-items vs FactSet 14.7p [2 est, 13.8-15.6p]

        • +3.7% SRAIL.SW (Stadler Rail) -- outperform from marketperform at Zürcher Kantonalbank

        • +3.6% RKT.LN (Reckitt Benckiser) -- Danone is again showing interest in buying Mead Johnson if Reckitt Benckiser decides to sell it -- La Lettre

        • +3.5% ADMIE.GA (Admie Holdings (IPTO)) -- FY net income €132.4M ex-items vs FactSet €136M [2 est, €117-155M]

        • +3.3% BELA.GA (Jumbo) -- Mar sales ~ +10% y/y

        • +3.3% RMV.LN (Rightmove) -- neutral from sell at Citi

        • +2.8% BAYN.GR (Bayer) -- executive says FY26 guidance unchanged following US announcement on patented pharmaceutical tariffs -- Reuters

        • +2.8% GBLB.BB (Groupe Bruxelles Lambert) -- FY25 NAVPS €105.37, (7%) vs year-ago €113.30 - Annual report

        • +2.7% MOTR.LN (Motorpoint Group) -- FY Trading Update: EBITDA £27.0M vs year-ago £23.9M

        • +2.4% LSG.NO (Lerøy Seafood Group) -- Q1 trading update: total harvest volume of salmon and trout (GWT) 39,900 vs year-ago 38,200

        • +2.1% ERA.FP (Eramet) -- largest shareholder the Duval family exploring sale of 37% stake as the company prepares €500M capital raise - FT

        • +2.1% PEY.LN (Partners Group Private Equity) -- to allocate €18M to its share buyback program

        • +2.0% VNV.SS (VNV Global) -- proposes election of Lars-Åke Norling as chairman

        • +1.5% SIGHT.FP (GenSight Biologics) -- cash and cash equivalent of €3.2M as of 31-Mar-26 vs €2.4M as of 31-Dec-25

      • Notable Decliners

        • -30.0% TRLS.LN (Trellus Health) -- issues 48.7M new shares following the conversion of £50K of the principal amount outstanding of the secured convertible loan notes

        • -13.3% CRNA.NO (Circio Holding) -- prelim H2 operating income (NOK21M)

        • -8.7% OXUR.BB (Oxurion) -- postpones Annual Shareholders Meeting to 1-Jun

        • -5.5% VPK.NA (Royal Vopak) -- neutral from outperform at Oddo

        • -5.1% SHEL.LN (Shell) -- publishes Q1 update note ahead next results release on 7-May

        • -2.5% BHG.SS (BHG Group) -- hold from buy at Danske Bank

        • -1.6% SNR.LN (Senior) -- Advent International confirmed that it does not intend to make an offer

    • EU companies reporting tomorrow:

      • Earnings:

        • DACHs: CENIT (CSH.GR)

        • France: Robertet (RBT.FP), Mauna Kea Technologies (ALKMT.FP), OVH Groupe (OVH.FP)

        • Nordics: Duell (DUELL.FH)

        • Southern Europe: Metlen Energy & Metals (MTLN.GA)

      • Trading Update:

        • Benelux: Fagron (FAGR.BB)

        • DACHs: OMV (OMV.AV)

        • Southern Europe: Brunello Cucinelli (BC.IM)

      • Sales: Clas Ohlson (CLAS.B.SS)

      • Traffic: Finnair (FIA1S.FH), Norwegian Air Shuttle (NAS.NO)

      • CMD/Events: ConvaTec Group (CTEC.LN)

  • Data:

    • Economics:

      • Germany

        • Mar construction PMI 48.0 vs consensus 44.5, prior 43.7

        • Feb factory orders +0.9% m/m vs consensus +3.0%, prior (11.1%)

      • UK Mar

        • Construction PMI 45.6 vs consensus 43.9, prior 44.5

        • House price index +0.8% y/y vs consensus +1.5%, prior revised +1.2% from +1.3% - Halifax release

      • France Feb trade balance (€5.8B) vs consensus (€2.4B), prior revised (€2.0B) from (€1.8B)

      • Switzerland Mar unemployment rate (sa) 3.0% vs consensus 3.0%, prior 3.0%; (nsa) 3.1% vs consensus 3.2%, prior 3.2%

      • Eurozone Feb

        • PPI (3.0%) y/y vs consensus (3.0%), prior revised (2.0%) from (2.1%)

        • Retail sales +1.7% y/y vs consensus +1.6%, prior revised +2.1% from +2.0%

    • Markets:

      • WTI Crude (May 26): ($17.48) or (15.48%) to $95.47

      • €-$ +0.0095 or +0.82% to 1.1693

      • £-$ +0.0151 or +1.14% to 1.3443

      • €-£ (0.0023) to 0.8700

      • S&P 500 +2.12%

      • Performance year-to-date:

        • FTSE 100: +6.70%

        • DAX: (1.97%)

        • CAC: +1.32%

        • MIB: +4.46%

        • Stoxx 600: +3.42%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.